Keane K. Y. Lai

953 total citations
25 papers, 741 citations indexed

About

Keane K. Y. Lai is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Keane K. Y. Lai has authored 25 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in Keane K. Y. Lai's work include Wnt/β-catenin signaling in development and cancer (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cancer-related gene regulation (4 papers). Keane K. Y. Lai is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cancer-related gene regulation (4 papers). Keane K. Y. Lai collaborates with scholars based in United States, Japan and Hong Kong. Keane K. Y. Lai's co-authors include Hidekazu Tsukamoto, Laura Beretta, Samuel W. French, Deepak Kolippakkam, Aurelia Lugea, Cheng Ji, Jun Xu, Marcus P. Cooper, Alla Verlinsky and Jane F. Emerson and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Keane K. Y. Lai

25 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keane K. Y. Lai United States 16 344 264 130 125 117 25 741
Enara Arretxe Spain 11 329 1.0× 302 1.1× 93 0.7× 70 0.6× 135 1.2× 14 668
David Fernández‐Ramos Spain 18 717 2.1× 309 1.2× 132 1.0× 122 1.0× 189 1.6× 31 1.1k
Kangkang Yu China 16 331 1.0× 255 1.0× 161 1.2× 84 0.7× 190 1.6× 44 708
Claudia Martelli Italy 15 241 0.7× 162 0.6× 116 0.9× 120 1.0× 73 0.6× 28 743
Michèle Egger Switzerland 4 253 0.7× 352 1.3× 320 2.5× 187 1.5× 250 2.1× 4 866
Elena Kotsiliti United Kingdom 2 295 0.9× 662 2.5× 339 2.6× 98 0.8× 186 1.6× 2 988
Zhenzhen Yao China 10 378 1.1× 141 0.5× 108 0.8× 150 1.2× 145 1.2× 17 802
Antoine L’Hermitte United States 8 391 1.1× 131 0.5× 102 0.8× 151 1.2× 204 1.7× 10 672
Kimberly Viker United States 13 217 0.6× 568 2.2× 192 1.5× 73 0.6× 42 0.4× 18 915
Caryn L. Elsegood Australia 16 227 0.7× 161 0.6× 140 1.1× 95 0.8× 119 1.0× 30 692

Countries citing papers authored by Keane K. Y. Lai

Since Specialization
Citations

This map shows the geographic impact of Keane K. Y. Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keane K. Y. Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keane K. Y. Lai more than expected).

Fields of papers citing papers by Keane K. Y. Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keane K. Y. Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keane K. Y. Lai. The network helps show where Keane K. Y. Lai may publish in the future.

Co-authorship network of co-authors of Keane K. Y. Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Keane K. Y. Lai. A scholar is included among the top collaborators of Keane K. Y. Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keane K. Y. Lai. Keane K. Y. Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kweon, Soo-Mi, et al.. (2022). Midnolin Regulates Liver Cancer Cell Growth In Vitro and In Vivo. Cancers. 14(6). 1421–1421. 13 indexed citations
2.
Wang, Lixia, Ju Dong Yang, Keane K. Y. Lai, et al.. (2022). Magnetic resonance imaging for characterization of hepatocellular carcinoma metabolism. Frontiers in Physiology. 13. 1056511–1056511. 4 indexed citations
3.
Chang, Ya-Wen, Mingtian Che, Mei‐Hui Wang, et al.. (2021). Thioacetamide-Induced Norepinephrine Production by Hepatocytes is Associatedwith Hepatic Stellate Cell Activation and Liver Fibrosis. Current Molecular Pharmacology. 15(2). 454–461. 6 indexed citations
4.
Lai, Keane K. Y., Cu Nguyen, David Pei‐Cheng Lin, et al.. (2021). p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair. Cancers. 13(6). 1288–1288. 11 indexed citations
5.
Lai, Keane K. Y. & Michaël Kahn. (2021). Pharmacologically Targeting the WNT/β-Catenin Signaling Cascade: Avoiding the Sword of Damocles. Handbook of experimental pharmacology. 269. 383–422. 5 indexed citations
6.
Che, Mingtian, Soo-Mi Kweon, Jia-Ling Teo, et al.. (2020). Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells. Cancers. 12(6). 1476–1476. 16 indexed citations
7.
Huang, Fung‐Yu, Fen Liu, James Fung, et al.. (2020). HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA. Scientific Reports. 10(1). 802–802. 23 indexed citations
8.
Lukaszewicz, Agnès, Cu Nguyen, David Pei‐Cheng Lin, et al.. (2019). The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300. Cancers. 11(7). 962–962. 10 indexed citations
9.
Huang, Fung‐Yu, Danny Ka‐Ho Wong, Wai‐Kay Seto, et al.. (2019). Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma. BMC Cancer. 19(1). 789–789. 13 indexed citations
10.
Asahina, Kinji, Emily S. Wan, Yibu Chen, et al.. (2019). Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras. American Journal of Physiology-Gastrointestinal and Liver Physiology. 318(2). G265–G276. 16 indexed citations
11.
Ono, Masaya, Keane K. Y. Lai, Kaijin Wu, et al.. (2018). Nuclear receptor/Wnt beta-catenin interactions are regulated via differential CBP/p300 coactivator usage. PLoS ONE. 13(7). e0200714–e0200714. 17 indexed citations
12.
Manegold, Philipp, Keane K. Y. Lai, Yongfeng Wu, et al.. (2018). Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. Cancers. 10(4). 95–95. 43 indexed citations
13.
14.
Kweon, Soo-Mi, Feng Chi, Reiichi Higashiyama, Keane K. Y. Lai, & Hidekazu Tsukamoto. (2016). Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells. PLoS ONE. 11(5). e0156111–e0156111. 23 indexed citations
15.
Lai, Keane K. Y., et al.. (2013). Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography–tandem mass spectrometry. Clinical Biochemistry. 46(12). 1118–1124. 32 indexed citations
16.
Emerson, Jane F. & Keane K. Y. Lai. (2013). Endogenous Antibody Interferences in Immunoassays. Laboratory Medicine. 44(1). 69–73. 28 indexed citations
17.
Lai, Keane K. Y., et al.. (2011). Extracellular Matrix Dynamics in Hepatocarcinogenesis: a Comparative Proteomics Study of PDGFC Transgenic and Pten Null Mouse Models. PLoS Genetics. 7(6). e1002147–e1002147. 77 indexed citations
18.
Lai, Keane K. Y., et al.. (2011). Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay. Clinical Chemistry. 57(7). 1050–1056. 28 indexed citations
19.
Xu, Jun, Keane K. Y. Lai, Alla Verlinsky, et al.. (2011). Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. Journal of Hepatology. 55(3). 673–682. 123 indexed citations
20.
Lai, Keane K. Y., Deepak Kolippakkam, & Laura Beretta. (2008). Comprehensive and quantitative proteome profiling of the mouse liver and plasma. Hepatology. 47(3). 1043–1051. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enara Arretxe Breakdown of academic impact, for papers by David Fernández‐Ramos Breakdown of academic impact, for papers by Kangkang Yu Breakdown of academic impact, for papers by Claudia Martelli Breakdown of academic impact, for papers by Michèle Egger Breakdown of academic impact, for papers by Elena Kotsiliti Breakdown of academic impact, for papers by Zhenzhen Yao Breakdown of academic impact, for papers by Antoine L’Hermitte Breakdown of academic impact, for papers by Kimberly Viker Breakdown of academic impact, for papers by Caryn L. Elsegood
Rankless by CCL
2026